These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12455036)

  • 1. Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis.
    Lai HC; Sytwu HK; Sun CA; Yu MH; Yu CP; Liu HS; Chang CC; Chu TY
    Int J Cancer; 2003 Jan; 103(2):221-5. PubMed ID: 12455036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas gene promoter -670 polymorphism (A/G) is associated with cervical carcinogenesis.
    Ueda M; Hung YC; Terai Y; Yamaguchi H; Saito J; Nunobiki O; Noda S; Ueki M
    Gynecol Oncol; 2005 Jul; 98(1):129-33. PubMed ID: 15894356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction.
    Lai HC; Lin WY; Lin YW; Chang CC; Yu MH; Chen CC; Chu TY
    Gynecol Oncol; 2005 Oct; 99(1):113-8. PubMed ID: 15996722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of the interferon-gamma gene in cervical carcinogenesis.
    Lai HC; Chang CC; Lin YW; Chen SF; Yu MH; Nieh S; Chu TW; Chu TY
    Int J Cancer; 2005 Feb; 113(5):712-8. PubMed ID: 15499631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study.
    McCormick TM; Canedo NH; Furtado YL; Silveira FA; de Lima RJ; Rosman AD; Almeida Filho GL; Carvalho Mda G
    Diagn Pathol; 2015 Jun; 10():59. PubMed ID: 26032781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between polymorphisms in the FAS/FASL death receptor system and progression of low-grade precursor lesions infected with high-risk human papilloma virus.
    Santaclara V; Torres-Moreno D; Bernal-Mañas CM; Isaac MA; Ortiz-Reina S; Conesa-Zamora P
    Hum Immunol; 2021 Sep; 82(9):621-624. PubMed ID: 34127318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.
    Chatterjee K; Dandara C; Hoffman M; Williamson AL
    BMC Cancer; 2010 Jun; 10():278. PubMed ID: 20537184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 SNP 309 human papillomavirus infection in cervical carcinogenesis.
    Nunobiki O; Ueda M; Yamamoto M; Toji E; Sato N; Izuma S; Okamoto Y; Torii K; Noda S
    Gynecol Oncol; 2010 Sep; 118(3):258-61. PubMed ID: 20538323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble interleukin 2 receptor levels and cervical neoplasia: results from a population-based case-control study in Costa Rica.
    Ung A; Kramer TR; Schiffman M; Herrero R; Bratti MC; Burk RD; Swanson CA; Sherman ME; Hutchinson ML; Alfaro M; Morales J; Balmaceda I; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):249-53. PubMed ID: 10090303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias.
    Lai HC; Lin YW; Chang CC; Wang HC; Chu TW; Yu MH; Chu TY
    Gynecol Oncol; 2007 Mar; 104(3):629-35. PubMed ID: 17097722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.
    Khouadri S; Villa LL; Gagnon S; Koushik A; Richardson H; Matlashewski G; Roger M; Ferenczy AS; Franco EL; Coutlée F
    Int J Cancer; 2007 Dec; 121(12):2674-81. PubMed ID: 17708553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of low and high grade squamous intraepithelial lesions of the cervix: morphologic progression or multiple papillomaviruses?
    Park J; Sun D; Genest DR; Trivijitsilp P; Suh I; Crum CP
    Gynecol Oncol; 1998 Sep; 70(3):386-91. PubMed ID: 9790792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence of the involvement of the Fas -670 promoter polymorphism in cervical cancer in situ.
    Engelmark MT; Renkema KY; Gyllensten UB
    Int J Cancer; 2004 Dec; 112(6):1084-5. PubMed ID: 15316939
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential viral loads of human papillomavirus 16 and 58 infections in the spectrum of cervical carcinogenesis.
    Lai HC; Peng MY; Nieh S; Yu CP; Chang CC; Lin YW; Sun CA; Chu TY
    Int J Gynecol Cancer; 2006; 16(2):730-5. PubMed ID: 16681753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the association of NKG2C copy number variations with susceptibility to human papillomavirus-induced cervical lesions.
    Vilchez JR; Torres-Moreno D; Martínez-Senac MM; Trujillo-Santos J; Conesa-Zamora P
    Hum Immunol; 2013 Oct; 74(10):1352-6. PubMed ID: 23911737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Fas gene promoter polymorphism in cervical cancer patients.
    Dybikowska A; Sliwinski W; Emerich J; Podhajska AJ
    Int J Mol Med; 2004 Sep; 14(3):475-8. PubMed ID: 15289903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione-S-transferase and p53 polymorphisms in cervical carcinogenesis.
    Ueda M; Hung YC; Terai Y; Saito J; Nunobiki O; Noda S; Ueki M
    Gynecol Oncol; 2005 Mar; 96(3):736-40. PubMed ID: 15721419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of human papillomavirus genotypes in archival cervical lesions in eastern inner Mongolian autonomous region, China.
    Wu EQ; Yu XH; Zha X; Zhang GN; Wang JH; Fan Y; Tang YY; Zhao ZX; Wu YG; Kong W
    Int J Gynecol Cancer; 2009 Jul; 19(5):919-23. PubMed ID: 19574785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
    Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer.
    Lai HC; Chu CM; Lin YW; Chang CC; Nieh S; Yu MH; Chu TY
    Gynecol Oncol; 2005 Feb; 96(2):314-9. PubMed ID: 15661214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.